|
Canada-0-MEDITATION ไดเรกทอรีที่ บริษัท
|
ข่าว บริษัท :
- NCCN - National Comprehensive Cancer Network - Home
NCCN is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education NCCN is dedicated to defining and advancing quality, effective, equitable, and accessible cancer care and prevention so all people can live better lives
- NCCN (National Comprehensive Cancer Network) Guidelines
NCCN is a not for profit organization composed of 28 leading cancer centers across the US whose focus is on patient care, research, and education The overarching goal is quality patient outcomes
- Conexiant - National Comprehensive Cancer Network
World-renowned experts from NCCN Member Institutions diagnose and treat patients with a broad spectrum of cancers and are recognized for dealing with complex, aggressive, or rare cancers
- NCCN Clinical Practice Guidelines in Oncology: 2025 Updates
The National Comprehensive Cancer Network (NCCN) released its first set of Clinical Practice Guidelines in Oncology (NCCN Guidelines®) in 1996, covering eight tumor types Today, guidelines are available for more than 60 tumor types, subtypes, and related topics
- NCCN Guidelines® Insights: Non-Small Cell Lung Cancer . . . - PubMed
These NCCN Guidelines Insights discuss recent updates to the NCCN Guidelines, with a focus on systemic therapy options for the treatment of patients with nonmetastatic NSCLC and the corresponding molecular testing considerations
- NCCN guideline preview: 5 upcoming changes every oncologist should know
The National Comprehensive Cancer Network (NCCN) is a key player in today’s cancer care, developing cutting-edge, evidence-based recommendations on everything from screening and diagnosis to treatment and supportive care
- NCCN
The National Comprehensive Cancer Network ® (NCCN ®), is a not-for-profit alliance of 33 leading cancer centers devoted to patient care, research, and education
- NCCN Breast Cancer Guidelines 2025: Clinical Practice in Oncology
NCCN Clinical Practice Guidelines for Breast Cancer, Version 4 2025 Comprehensive oncology guidelines with evidence-based recommendations for breast cancer diagnosis, treatment, and management, updated April 2025
- NCCN 2026 Bladder Cancer Guidelines Adopt IBCG Risk Stratification . . .
The 2026 NCCN Bladder Cancer Guidelines incorporate the IBCG five-factor model, introducing standardized risk stratification for intermediate-risk NMIBC
- NCCN guidelines adopt IBCG risk model for intermediate-risk NMIBC
NCCN now subdivides intermediate-risk NMIBC into three actionable strata, enabling more consistent selection of surveillance, intravesical therapy, and adjuvant intensification pathways IBCG risk factors include multifocality, size ≥3 cm, recurrence within 1 year, >1 recurrence year, and prior
|
|